ArticleNaunyn-Schmiedeberg's archives of pharmacology2021

Nanotechnology improves the therapeutic efficacy of gemcitabine against a human hepatocellular carcinoma cell line and minimizes its in vivo side effects.

Sawsan M A El-Sheikh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.